Off-label drug marketing gets free-speech protection in court ruling – American Medical News

by admin on December 24, 2012

Off-label drug marketing gets free-speech protection in court ruling
American Medical News
Federal investigators found that Caronia was recommending Xyrem to physicians for patients with fibromyalgia, restless leg syndrome and chronic fatigue. Under the federal Food Drug and Cosmetic Act, drugmakers are prohibited from marketing drugs for

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: